The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for InVitae sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
InVitae Corp (InVitae) is a medical genetics company that provides testing, health data and digital health solutions for various genetic disorders. The company provides genetic testing services in multiple clinical areas that include hereditary cancer, women’s health, precision oncology, pharmacogenomics and rare diseases. It uses process automation, proprietary design, robotics and bioinformatics software solutions to support genetic counseling, variant interpretation, and clinical trial matching. The company serves payers, healthcare providers, biopharma partners and patient advocacy groups. It operates in Australia, India, Japan, Singapore, Belgium, Germany, Latvia, the Netherlands, the US, Israel and Brazil. InVitae is headquartered in San Francisco, California, the US. Key subsidiaries of InVitae include InVitae Netherlands, PatientCrossroads, InVitae Australia, InVitae Israel and Jungla.
The key metrics of InVitae related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As InVitae is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as InVitae.
For a detailed understanding of the performance of InVitae, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
